Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma. 1990

I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
UNICET, Laboratory for Immunology Research, Dardilly, France.

In the present study culture conditions resulting in optimal IgE synthesis by mononuclear cells (MNC) isolated from peripheral blood, tonsils or spleens from healthy nonallergic donors were investigated. The highest rate of IgE synthesis was obtained in a two-step culture system in which the MNC were preincubated with interleukin 4 (IL4; 200 U/ml) for 48 h, washed and subsequently incubated with IL4 (200 U/ml) for 9 days. Despite these culture conditions, IL4-induced IgE synthesis varied considerably (1-150 ng/ml) and MNC from 16/70 donors failed to produce IgE. Kinetic studies indicated that IL4 was required at the onset of the incubation phase. IgE synthesis was reduced by greater than 95% when addition of IL4 in the incubation period was delayed 24 h or more. IL4-induced IgE synthesis was blocked by interferon-gamma (IFN-gamma). This inhibition is most effective when IFN-gamma was added in the 48-h preincubation step or during the first 48 h of the incubation period. Interestingly, IL4 was found to block spontaneous and lectin- or factor-induced IFN-gamma production by MNC, purified CD3+, CD4+ or CD8+ Tcells. This down-regulatory effect of IL4 on IFN-gamma production occurred at the mRNA transcription level. Furthermore, it is shown that IL4 induced the release of soluble CD23 and that recombinant soluble CD23 enhanced IL4-induced IgE synthesis, but only when IL4 was present at suboptimal concentrations. Collectively, our data indicate that IL4 and IFN-gamma regulate the level of IgE synthesis by influencing each other's activities reciprocally during the first 3 days of the culture.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000944 Antigens, Differentiation, B-Lymphocyte Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin. Antigens, Differentiation, B-Cell,B-Cell Differentiation Antigens,B-Lymphocyte Differentiation Antigens,Blast-2 Antigen, B-Cell,Differentiation Antigens, B-Cell,Differentiation Antigens, B-Lymphocyte,Leu Antigens, B-Lymphocyte,Plasma Cell Antigens PC-1,Antigens, Differentiation, B Lymphocyte,Antigens, Plasma Cell, PC-1,B-Cell Blast-2 Antigen,Antigen, B-Cell Blast-2,Antigens, B-Cell Differentiation,Antigens, B-Lymphocyte Differentiation,Antigens, B-Lymphocyte Leu,B Cell Blast 2 Antigen,B Cell Differentiation Antigens,B Lymphocyte Differentiation Antigens,B-Lymphocyte Leu Antigens,Blast 2 Antigen, B Cell,Differentiation Antigens, B Cell,Differentiation Antigens, B Lymphocyte,Leu Antigens, B Lymphocyte,Plasma Cell Antigens PC 1
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
January 1989, International archives of allergy and applied immunology,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
January 1987, La Ricerca in clinica e in laboratorio,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
August 1997, The Journal of investigative dermatology,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
September 1996, European journal of biochemistry,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
January 1995, International archives of allergy and immunology,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
January 1991, International archives of allergy and applied immunology,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
September 1992, The Journal of allergy and clinical immunology,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
January 1988, The Journal of experimental medicine,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
November 1998, Scandinavian journal of immunology,
I Chrétien, and J Pène, and F Brière, and R De Waal Malefijt, and F Rousset, and J E De Vries
March 2001, Infection and immunity,
Copied contents to your clipboard!